Warburg Research set a €115.00 ($135.29) target price on Merck KGaA (FRA:MRK) in a report published on Monday morning. The firm currently has a buy rating on the healthcare company’s stock.

Other research analysts also recently issued reports about the company. HSBC Holdings plc set a €94.00 ($110.59) price target on Merck KGaA and gave the company a neutral rating in a report on Wednesday, August 9th. Independent Research GmbH set a €105.00 ($123.53) price objective on Merck KGaA and gave the stock a neutral rating in a research note on Wednesday, September 6th. Berenberg Bank set a €116.00 ($136.47) price objective on Merck KGaA and gave the stock a buy rating in a research note on Tuesday, September 19th. Citigroup Inc. set a €123.00 ($144.71) price objective on Merck KGaA and gave the company a buy rating in a research report on Monday, September 25th. Finally, Deutsche Bank AG set a €106.00 ($124.71) price objective on Merck KGaA and gave the company a neutral rating in a research report on Wednesday, July 26th. Thirteen equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The stock currently has an average rating of Hold and an average price target of €109.61 ($128.95).

Merck KGaA (FRA MRK) opened at 95.478 on Monday. The stock has a market cap of €41.51 billion and a price-to-earnings ratio of 24.890. The stock has a 50 day moving average price of €94.70 and a 200 day moving average price of €101.98. Merck KGaA has a 52-week low of €89.00 and a 52-week high of €115.00.

COPYRIGHT VIOLATION NOTICE: This piece was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States and international copyright and trademark law. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/10/03/merck-kgaa-mrk-given-a-115-00-price-target-at-warburg-research.html.

About Merck KGaA

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.